EPO | Intellepedia

After Natco, Bajaj Healthcare files compulsory license against Eli Lilly; EPO Enlarged Board of Appeal issues decision on ‘double patenting’ and more

Bajaj Healthcare has applied for a compulsory license against Eli Lilly for Baricitinib, citing affordability concerns. The post also covers the EPO’s decision on double patenting, updates from the IP5 meeting on AI patents, and new initiatives by WHO, WTO, and WIPO.

IPO & JPO to be competent ISA & IPEA to each other under PCT, EPO publishes patent index 2020 and more

India and Japan will act as competent ISA and IPEA for each other’s PCT filings from July 2021. Apple faces a $308.5 million patent infringement fine, while the EPO’s 2020 patent index shows strong innovation in healthcare and medical technology.

IBM #1 patent filer in 2020, Samsung at #2, Court rules in favor of Garmin in patent suit involving Philips and more

This post reports on major patent developments, including IBM and Samsung’s US patent rankings for 2020 and the ITC’s decision in favour of Garmin over Philips. It also covers international updates regarding patent prosecution, COVID-19 vaccine patent waivers, and a new EPO study on intellectual property benefits.

CPI(M) asks Government to issue compulsory license for Remdesivir, EPO creates search strategies to help fight against COVID-19 and more patent news

The CPI(M) has urged the Indian government to issue a compulsory license for Remdesivir to facilitate generic manufacturing. Additionally, the EPO has developed new patent search strategies for COVID-19, and an upcoming EUIPO-EPO conference will address intellectual property issues in additive manufacturing.

COVID crisis threatens Gilead’s patent on Remdesvir, EPO’s Enlarged Board of Appeal issues opinion on plant and animal patentability, India asks G20 to establish agreement enabling use of TRIPS flexibilities and other patent news

The post analyses patent law updates relating to COVID-19, including India’s push for TRIPS flexibilities and scrutiny of Gilead’s Remdesvir patent. It also covers the EPO’s stance on plant and animal patentability and new global initiatives in IP law enforcement.

National Startup Advisory Council to be set up by Central Government, EPO publishes six search reports and more

The Central Government is set to establish the National Startup Advisory Council to enhance India’s startup ecosystem and support IP protection. This week’s bulletin also covers major patent news from India and abroad, including updates from HCL, EPO, and ongoing patent disputes.

Machines cannot be inventors rules EPO, Toyota launches new IP Licensing Program and other patent updates

The EPO has ruled that machines cannot be recognized as inventors, marking a significant stance in patent law. Toyota launches an IP Licensing Program, while Michelin pursues a design patent infringement suit. Key updates from the Indian Patent Office and international patent cooperation are also covered.

One more way to speedy patents in India approved, EPO launches revamped Espacenet and other patent news

The Union Cabinet’s approval of the Patent Prosecution Highway with Japan marks a notable step for faster patents in India, especially for startups and MSMEs. Additional highlights include EPO’s launch of the new Espacenet search tool, WIPO’s publication of leading IP judgments, and key Indian Patent Office updates.

Re-Classifying Patent Search- Cooperative Patent Classification (CPC)

This post reviews the development of the Cooperative Patent Classification system by the EPO and USPTO to streamline patent classification globally. It addresses the challenges of using multiple systems and the anticipated benefits of CPC in patent searches.

Google, Akamai and Netflix accused of patent infringement, Certificate Course on Patent Law, EPO discusses patentability of plants obtained by essentially biological processes, Microsoft adds 500 to LOT Network and more

This update examines key patent news including Indian patent statistics, infringement cases against major tech firms, and international developments at the EPO and in China. It also covers Microsoft’s patent contributions to the LOT Network and recent educational initiatives in patent law.